The Science of Doing Right: Reflections on a Global Mental Health Advocacy Project
Background: In July 2013, the World Health Organization (WHO) approved an application submitted by Mount Sinai physicians, Dr Craig Katz, Dr Anna Rosen, and Dr Hiwot Woldu, and medical student Jasleen Salwan to add risperidone to the <a title="Learn more about Essential medicines" href=...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Ubiquity Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d197cbf506ac4077a0ce56ebcaedb657 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Background: In July 2013, the World Health Organization (WHO) approved an application submitted by Mount Sinai physicians, Dr Craig Katz, Dr Anna Rosen, and Dr Hiwot Woldu, and medical student Jasleen Salwan to add risperidone to the <a title="Learn more about Essential medicines" href="https://www.sciencedirect.com/topics/medicine-and-dentistry/essential-medicines">Essential Medicines List</a>. Initiated in 1977 and updated every 2 years based on applications for revisions submitted by parties outside WHO, the list guides drug policy in developing nations around the world. Although it is not binding, it helps government officials as well as external donors set funding priorities.</p><p id="abspara0015">WHO’s approval of the Mount Sinai team’s application marked the first addition of an <a title="Learn more about Atypical antipsychotic" href="https://www.sciencedirect.com/topics/medicine-and-dentistry/atypical-antipsychotic">atypical antipsychotic</a> to the list, addressing a major neglected area of global health. It is hoped that it will be followed by many more victories for underserved psychiatric patients across the globe. |
|---|